Abstract

This research employs multiple linear regressions to explore the impacts of intellectual capital on corporate performance of biotechnology and pharmaceutical firms from perspective of multimedia data applications in Taiwan. We divided multimedia data of intellectual capital into four main components: human capital, process capital, innovation capital, and customer capital. The sample includes companies listed in Taiwan Stock Exchange (TSE) and Taipei exchange market for the period 2007 to 2013. The results show that the association between innovation capital and performance is positive. The human capital and process capital partially improve firms' performance while customer capital did not significantly improve the accounting performance. The results suggest the role of intellectual capital and innovation capital in enhancing the financial performance of companies in biotechnology and pharmaceutical industry. From the web-scale experience, the finding serves as valuable information for investors while making investment decisions.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call